Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Nonoperative management after neoadjuvant therapy for rectal cancer: A single institution experience over 5 years.

Strode M, Shah R, Boland PM, Francescutti VA, Mangieri CW, Attwood K, Nurkin SJ.

Surg Oncol. 2019 Mar;28:116-120. doi: 10.1016/j.suronc.2018.11.012. Epub 2018 Nov 13.

PMID:
30851884
2.

Stage II-III colon cancer: a comparison of survival calculators.

Lemini R, Attwood K, Pecenka S, Grego J, Spaulding AC, Nurkin S, Colibaseanu DT, Gabriel E.

J Gastrointest Oncol. 2018 Dec;9(6):1091-1098. doi: 10.21037/jgo.2018.08.03.

3.

Association of Clinicopathologic and Molecular Markers on Stage-specific Survival of Right Versus Left Colon Cancer.

Narayanan S, Gabriel E, Attwood K, Boland P, Nurkin S.

Clin Colorectal Cancer. 2018 Dec;17(4):e671-e678. doi: 10.1016/j.clcc.2018.07.001. Epub 2018 Jul 5.

PMID:
30108021
4.

A novel anesthesiologist-led multidisciplinary model for evaluating high-risk surgical patients at a comprehensive cancer center.

Sroka R, Gabriel EM, Al-Hadidi D, Nurkin SJ, Urman RD, Quinn TD.

J Healthc Risk Manag. 2019 Jan;38(3):12-23. doi: 10.1002/jhrm.21326. Epub 2018 Jul 23.

PMID:
30033650
5.

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Benson AB 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Gurski L, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Jul;16(7):874-901. doi: 10.6004/jnccn.2018.0061.

PMID:
30006429
6.

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Benson AB 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Jul;16(7):852-871. doi: 10.6004/jnccn.2018.0060.

PMID:
30006428
7.

Disparities in major surgery for esophagogastric cancer among hospitals by case volume.

Gabriel E, Narayanan S, Attwood K, Hochwald S, Kukar M, Nurkin S.

J Gastrointest Oncol. 2018 Jun;9(3):503-516. doi: 10.21037/jgo.2018.01.18.

8.

Preoperative survival calculator for resectable hepatocellular carcinoma.

Gabriel E, Kim J, Ostapoff KT, Attwood K, Kurenov S, Kuvshinoff B, Hochwald SN, Nurkin SJ.

J Gastrointest Oncol. 2018 Apr;9(2):316-325. doi: 10.21037/jgo.2017.12.03.

9.

NCCN Guidelines Insights: Colon Cancer, Version 2.2018.

Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Garrido-Laguna I, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Apr;16(4):359-369. doi: 10.6004/jnccn.2018.0021.

PMID:
29632055
10.

Age-related rates of colorectal cancer and the factors associated with overall survival.

Gabriel E, Attwood K, Al-Sukhni E, Erwin D, Boland P, Nurkin S.

J Gastrointest Oncol. 2018 Feb;9(1):96-110. doi: 10.21037/jgo.2017.11.13.

11.

Association of Frailty With Failure to Rescue After Low-Risk and High-Risk Inpatient Surgery.

Shah R, Attwood K, Arya S, Hall DE, Johanning JM, Gabriel E, Visioni A, Nurkin S, Kukar M, Hochwald S, Massarweh NN.

JAMA Surg. 2018 May 16;153(5):e180214. doi: 10.1001/jamasurg.2018.0214. Epub 2018 May 16.

PMID:
29562073
12.

Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers.

Reyngold M, Niland J, Ter Veer A, Bekaii-Saab T, Lai L, Meyer JE, Nurkin SJ, Schrag D, Skibber JM, Benson AB, Weiser MR, Crane CH, Goodman KA.

Adv Radiat Oncol. 2017 Oct 12;3(1):34-41. doi: 10.1016/j.adro.2017.10.001. eCollection 2018 Jan-Mar.

13.

Does neoadjuvant/perioperative chemotherapy improve overall survival for T2N0 gastric adenocarcinoma?

Gabriel E, Attwood K, Narayanan S, Brady M, Nurkin S, Hochwald S, Kukar M.

J Surg Oncol. 2018 Mar;117(4):659-670. doi: 10.1002/jso.24894. Epub 2017 Nov 11.

PMID:
29127704
14.

Disparities in the Age-Related Rates of Colorectal Cancer in the United States.

Gabriel E, Ostapoff K, Attwood K, Al-Sukhni E, Boland P, Nurkin S.

Am Surg. 2017 Jun 1;83(6):640-647.

PMID:
28637568
15.

Interpreting the Evidence on Neoadjuvant Treatment of Esophageal Adenocarcinoma: In Reply to Yim and Colleagues.

Al-Sukhni E, Gabriel E, Attwood K, Kukar M, Nurkin SJ, Hochwald SN.

J Am Coll Surg. 2017 May;224(5):997-998. doi: 10.1016/j.jamcollsurg.2017.01.045. No abstract available.

PMID:
28449936
16.

Enhanced Recovery After Surgery for Noncolorectal Surgery?: A Systematic Review and Meta-analysis of Major Abdominal Surgery.

Visioni A, Shah R, Gabriel E, Attwood K, Kukar M, Nurkin S.

Ann Surg. 2018 Jan;267(1):57-65. doi: 10.1097/SLA.0000000000002267. Review.

PMID:
28437313
17.

Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma?

Ostapoff KT, Gabriel E, Attwood K, Kuvshinoff BW, Nurkin SJ, Hochwald SN.

HPB (Oxford). 2017 Jul;19(7):587-594. doi: 10.1016/j.hpb.2017.03.002. Epub 2017 Apr 19.

18.

Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.

Shahab D, Gabriel E, Attwood K, Ma WW, Francescutti V, Nurkin S, Boland PM.

Clin Colorectal Cancer. 2017 Dec;16(4):300-307. doi: 10.1016/j.clcc.2017.03.005. Epub 2017 Mar 18.

19.

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Benson AB 3rd, Venook AP, Cederquist L, Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF, Enzinger PC, Fichera A, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wu CS, Gregory KM, Freedman-Cass D.

J Natl Compr Canc Netw. 2017 Mar;15(3):370-398.

PMID:
28275037
20.

National Disparities in Surgical Approach to T1 Rectal Cancer and Impact on Outcomes.

Gabriel E, Thirunavukarasu P, Al-Sukhni E, Attwood K, Nurkin SJ.

Am Surg. 2016 Nov 1;82(11):1080-1091.

PMID:
28206935
21.

Primary tumor resection does not improve survival among patients with unresectable colorectal cancer metastases-But who determines resectability?

Reddy SK, Boland PM, Nurkin SJ.

Cancer. 2017 Apr 1;123(7):1089-1091. doi: 10.1002/cncr.30595. Epub 2017 Feb 8. No abstract available.

22.

Novel Calculator to Estimate Overall Survival Benefit from Neoadjuvant Chemoradiation in Patients with Esophageal Adenocarcinoma.

Gabriel E, Attwood K, Shah R, Nurkin S, Hochwald S, Kukar M.

J Am Coll Surg. 2017 May;224(5):884-894.e1. doi: 10.1016/j.jamcollsurg.2017.01.043. Epub 2017 Jan 29.

23.

Commentary on "Insurance Status, Not Race, is Associated With Use of Minimally Invasive Surgical Approach for Rectal Cancer".

Gabriel E, Al-Sukhni E, Nurkin S.

Ann Surg. 2018 Feb;267(2):e29-e30. doi: 10.1097/SLA.0000000000001973. No abstract available.

PMID:
27977423
24.

No Survival Difference with Neoadjuvant Chemoradiotherapy Compared with Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: Results from the National Cancer Data Base.

Al-Sukhni E, Gabriel E, Attwood K, Kukar M, Nurkin SJ, Hochwald SN.

J Am Coll Surg. 2016 Dec;223(6):784-792.e1. doi: 10.1016/j.jamcollsurg.2016.09.002. Epub 2016 Sep 15.

PMID:
27641320
25.

Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: A retrospective cohort study.

Al-Sukhni E, Attwood K, Gabriel EM, LeVea CM, Kanehira K, Nurkin SJ.

Int J Surg. 2017 Jan;37:42-49. doi: 10.1016/j.ijsu.2016.08.528. Epub 2016 Sep 4.

26.

National disparities in minimally invasive surgery for pancreatic tumors.

Gabriel E, Thirunavukarasu P, Attwood K, Nurkin SJ.

Surg Endosc. 2017 Jan;31(1):398-409. doi: 10.1007/s00464-016-4987-6. Epub 2016 Jul 13.

PMID:
27412124
27.

Predicting Individualized Postoperative Survival for Stage II/III Colon Cancer Using a Mobile Application Derived from the National Cancer Data Base.

Gabriel E, Attwood K, Thirunavukarasu P, Al-Sukhni E, Boland P, Nurkin S.

J Am Coll Surg. 2016 Mar;222(3):232-44. doi: 10.1016/j.jamcollsurg.2015.12.019. Epub 2015 Dec 23.

28.

Predictors of circumferential resection margin involvement in surgically resected rectal cancer: A retrospective review of 23,464 patients in the US National Cancer Database.

Al-Sukhni E, Attwood K, Gabriel E, Nurkin SJ.

Int J Surg. 2016 Apr;28:112-7. doi: 10.1016/j.ijsu.2016.01.098. Epub 2016 Feb 21.

29.

Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.

Al-Sukhni E, Attwood K, Mattson DM, Gabriel E, Nurkin SJ.

Ann Surg Oncol. 2016 Apr;23(4):1177-86. doi: 10.1245/s10434-015-5017-y. Epub 2015 Dec 14.

30.

Nationwide analysis of short-term surgical outcomes of minimally invasive esophagectomy for malignancy.

Thirunavukarasu P, Gabriel E, Attwood K, Kukar M, Hochwald SN, Nurkin SJ.

Int J Surg. 2016 Jan;25:69-75. doi: 10.1016/j.ijsu.2015.11.023. Epub 2015 Nov 18.

31.

Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.

Gabriel E, Attwood K, Du W, Tuttle R, Alnaji RM, Nurkin S, Malhotra U, Hochwald SN, Kukar M.

JAMA Surg. 2016 Mar;151(3):234-45. doi: 10.1001/jamasurg.2015.4068.

32.

National disparities in minimally invasive surgery for rectal cancer.

Gabriel E, Thirunavukarasu P, Al-Sukhni E, Attwood K, Nurkin SJ.

Surg Endosc. 2016 Mar;30(3):1060-7. doi: 10.1007/s00464-015-4296-5. Epub 2015 Jun 20.

33.

Rectal Cancer, Version 2.2015.

Benson AB 3rd, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Grothey A, Hochster HS, Hunt S, Kamel A, Kirilcuk N, Leong LA, Lin E, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Freedman-Cass D.

J Natl Compr Canc Netw. 2015 Jun;13(6):719-28; quiz 728.

PMID:
26085388
34.

Pre-operative unintentional weight loss as a risk factor for surgical outcomes after elective surgery in patients with disseminated cancer.

Thirunavukarasu P, Sanghera S, Singla S, Attwood K, Nurkin S.

Int J Surg. 2015 Jun;18:7-13. doi: 10.1016/j.ijsu.2015.03.021. Epub 2015 Apr 10.

35.

Ablative therapy for esophageal dysplasia and early malignancy: focus on RFA.

Tuttle R, Nurkin SJ, Hochwald SN.

Biomed Res Int. 2014;2014:642063. doi: 10.1155/2014/642063. Epub 2014 Jul 21. Review.

36.

Ablative therapies for colorectal polyps and malignancy.

Oxenberg J, Hochwald SN, Nurkin S.

Biomed Res Int. 2014;2014:986352. doi: 10.1155/2014/986352. Epub 2014 Jun 26. Review.

37.

Colon cancer, version 3.2014.

Benson AB 3rd, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, Messersmith W, Mulcahy MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Freedman-Cass DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Jul;12(7):1028-59.

PMID:
24994923
38.

Transhiatal versus transthoracic esophagectomy for esophageal cancer: a 2005-2011 NSQIP comparison of modern multicenter results.

Papenfuss WA, Kukar M, Attwood K, Kakarla VR, Chousleb S, Hochwald SN, Nurkin SJ.

J Surg Oncol. 2014 Sep;110(3):298-301. doi: 10.1002/jso.23637. Epub 2014 May 29.

PMID:
24891305
39.

Morbidity and mortality associated with gastrectomy for gastric cancer.

Papenfuss WA, Kukar M, Oxenberg J, Attwood K, Nurkin S, Malhotra U, Wilkinson NW.

Ann Surg Oncol. 2014 Sep;21(9):3008-14. doi: 10.1245/s10434-014-3664-z. Epub 2014 Apr 4.

PMID:
24700300
40.

Outcomes of endoscopic resection for high-grade dysplasia and esophageal cancer.

Nurkin SJ, Nava HR, Yendamuri S, LeVea CM, Nwogu CE, Groman A, Wilding G, Bain AJ, Hochwald SN, Khushalani NI.

Surg Endosc. 2014 Apr;28(4):1090-5.

PMID:
24232046
41.

Neoadjuvant chemoradiotherapy for esophageal/gastroesophageal carcinoma.

Platz TA, Nurkin SJ, Fong MK, Groman A, Flaherty L, Malhotra U, Levea CM, Yendamuri S, Warren GW, Nava HR, May KS.

J Gastrointest Oncol. 2013 Jun;4(2):137-43. doi: 10.3978/j.issn.2078-6891.2013.007.

42.

Quality of life after an esophagectomy.

Sanghera SS, Nurkin SJ, Demmy TL.

Surg Clin North Am. 2012 Oct;92(5):1315-35. doi: 10.1016/j.suc.2012.07.001. Epub 2012 Aug 15. Review.

PMID:
23026284
43.

Margin status, local recurrence, and survival: correlation or causation?

Nurkin SJ, Kane JM 3rd.

Surg Oncol Clin N Am. 2012 Apr;21(2):255-67. doi: 10.1016/j.soc.2011.12.002.

PMID:
22365518
44.

Elective laparoscopic versus open colectomy for diverticulosis: an analysis of ACS-NSQIP database.

Kakarla VR, Nurkin SJ, Sharma S, Ruiz DE, Tiszenkel H.

Surg Endosc. 2012 Jul;26(7):1837-42. doi: 10.1007/s00464-011-2142-y. Epub 2012 Jan 19.

PMID:
22258301
45.

Sexually transmitted diseases among patients with human immunodeficiency virus in northern Israel.

Joffe H, Bamberger E, Nurkin S, Kedem E, Kra-Oz Z, Pollack S, Srugo I.

Isr Med Assoc J. 2006 May;8(5):333-6.

46.

Subpleural microvascular flow velocities and shear rates in normal and septic mechanically ventilated rats.

Waisman D, Abramovich A, Brod V, Lavon O, Nurkin S, Popovski F, Rotschild A, Bitterman H.

Shock. 2006 Jul;26(1):87-94.

PMID:
16783203
47.

A rare complication of the closed tracheal suction system.

Nurkin S, Waisman D, Davkin O, Kessel I, Vinograd I, Rotschild A.

J Pediatr. 2004 Dec;145(6):858. No abstract available.

PMID:
15580220

Supplemental Content

Loading ...
Support Center